23 August 2022 : Original article
Management of Spontaneous Portosystemic Shunts in 231 Patients Who Underwent Living Donor Liver Transplantation: A Retrospective Study from a Single Center in Nagasaki, Japan
Takashi Hamada1ABCDEF, Masaaki Hidaka1ACDEF*, Akihiko Soyama
1ACDF, Takanobu Hara 1ADF, Hajime Imamura 1ADF, Hajime Matsushima 1ADF, Takayuki Tanaka1ADF, Tomohiko Adachi1ADF, Kengo Kanetaka 1DF, Susumu Eguchi1ADF
DOI: 10.12659/AOT.936371
Ann Transplant 2022; 27:e936371
Table 3 Characteristics of the non-ligation group (survivors vs non-survivors/re-transplantation).
| Survivors (n=26) | Non-survivors/re-transplantation (n=17) | P value | |
|---|---|---|---|
| Age, years | 58 (33–68) | 57 (40–66) | 0.84 |
| Sex, male | 13 (50.0) | 9 (52.9) | 1.00 |
| Etiology | |||
| HCV | 10 (38.5) | 9 (52.9) | |
| HBV | 7 (26.9) | 2 (11.8) | |
| Alcoholic cirrhosis | 2 (7.7) | 0 (0) | |
| PBC | 2 (7.7) | 2 (11.8) | |
| PSC | 2 (7.7) | 1 (5.9) | |
| Others | 3 (11.5) | 3 (17.6) | |
| HCC | 12 (46.2) | 9 (52.9) | 0.76 |
| Child-Pugh score | 10 (7–14) | 10 (7–14) | 0.98 |
| MELD score | 16.5 (8–38) | 16 (8–28) | 0.98 |
| Graft, left lobe | 15 (57.7) | 14 (82.4) | 0.11 |
| GW/SLV, % | 40.5 (26.4–60.3) | 37.4 (26.9–53.9) | 0.64 |
| Operative time, minutes | 818 (652–1159) | 814 (503–1000) | 0.56 |
| Blood loss, g | 7150 (1860–18 400) | 4500 (1,120–14 171) | 0.21 |
| Splenectomy | 18 (69.2) | 9 (52.9) | 0.34 |
| Postoperative hospital stay (days) | 49 (25–105) | 51 (19–112) | 0.90 |
| Data are presented as n (%) or median (range). HCV – hepatitis C virus; HBV – hepatitis B virus; PBC – primary biliary cirrhosis; PSC – primary sclerosing cholangitis; HCC – hepatocellular carcinoma; MELD – model for end-stage liver disease; GW – graft weight; SLV – standard liver volume. | |||